Please assess the completion status of the following clinical trial:

Trial Title: Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult (at least 18 years old)~* Undergoing a first heart transplant (no heart/kidney transplants), who receive their transplant at one of the study sites~* Specifically INCLUDED are patients on ventricular assist devices, and allosensitized recipients~Exclusion Criteria:~* Age less than 18~* Inability to provide proper informed consent~* Combined organ transplantation~* Re-Transplantation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Monotherapy (Type: ACTIVE_COMPARATOR): Tacrolimus alone
- Combination therapy (Type: ACTIVE_COMPARATOR): tacrolimus with mycophenolate mofetil

Based on this trial design, predict the completion outcome and termination type (if applicable).